Importantly, it appears now, from a number of studies, that in biliary regeneration, disease and cancer, the reiterative deployment of NOTCH2 and JAG1 promotes BEC, HPC and cancer cell proliferation and provides a specific signalling module that could be targeted therapeutically across disease states. This evidence concerns the gene NOTCH2 and cancer.